Multi-therapeutic approach to manage delivery in an alloimmunized patient with type 3 von Willebrand disease

被引：39

作者：

Boyer-Neumann, C

Dreyfus, M

Wolf, M

Veyradier, A

Meyer, D

机构：

[1] Hop Antoine Beclere, Serv Hematol Biol, F-92140 Clamart, France

[2] INSERM, U143, Le Kremlin Bicetre, France

[3] Hop Bicetre, Serv Hematol Biol, Le Kremlin Bicetre, France

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2003年 / 1卷 / 01期

关键词：

D O I：

10.1046/j.1538-7836.2003.00009.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：190 / 192

页数：3

共 11 条

[1]

Aledort LM, 2000, THROMB HAEMOSTASIS, V83, P637

[2] Alloantibody from a patient with severe von Willebrand disease inhibits von Willebrand factor-FVIII interaction [J].

Batlle, J ;

Loures, E ;

Vila, P ;

Hernandez, MC ;

Mendez, JA ;

Torea, J ;

Rendal, E ;

Couselo, MJ ;

Filgueira, A ;

Lopez, MF ;

Fernandez .

ANNALS OF HEMATOLOGY, 1997, 75 (03) :111-115

[3]

BERGAMASCHINI L, 1995, J LAB CLIN MED, V125, P348

[4]

Ciavarella N, 1996, HAEMOSTASIS, V26, P150

[5] THERAPEUTIC PROTEIN A IMMUNOADSORPTION - A REVIEW [J].

GJORSTRUP, P ;

WATT, RM .

TRANSFUSION SCIENCE, 1990, 11 (3-4) :281-302

[6]

Grossmann RE, 2000, THROMB HAEMOSTASIS, V83, P633

[7]

MANNUCCI PM, 1981, BLOOD, V57, P25

[8] ATHEROSCLEROSIS AND VONWILLEBRAND-FACTOR 9U. PREVALENCE OF SEVERE VONWILLEBRANDS DISEASE IN WESTERN-EUROPE AND ISRAEL [J].

MANNUCCI, PM ;

BLOOM, AL ;

LARRIEU, MJ ;

NILSSON, IM ;

WEST, RR .

BRITISH JOURNAL OF HAEMATOLOGY, 1984, 57 (01) :163-169

[9]

MANNUCCI PM, 1987, EUR J HAEMATOL, V39, P467

[10]

SADLER JE, 1994, THROMB HAEMOSTASIS, V71, P520

← 1 2 →